Paraguay greenlights use of Taiwanese COVID-19 vaccine


Source: MercoPress

 

Paraguayan health authorities Monday issued an emergency clearance for the use of the Taiwanese-developed Medigen COVID-19 vaccine, it was announced.

The National Directorate of Sanitary Surveillance (Dinavisa) authorized local health care practitioners to use MVC-COV1901 produced by Medigen Vaccine Biologics Corporation (MVC) in people over 18 years of age, Paraguay's Health Ministry said in a statement. The Taiwanese laboratory completed phase 3 of its clinical studies in the country since August last year, for which some 1,000 volunteers were summoned.

Dinavisa's approval came after a team of Paraguayan experts visited the production laboratories in Taiwan, it was reported.

 

Cont'd.

LINK: https://en.mercopress.com/2022/02/14/paraguay-greenlights-use-of-taiwanese-covid-19-vaccine